Quantcast

Subscribe to:
POZ magazine
Newsletters
Join POZ: Facebook MySpace Twitter Pinterest
Tumblr Google+ Flickr Instagram
POZ Personals
Sign In / Join
Username:
Password:
Welcome, Guest. Please login or register.
November 27, 2014, 02:57:38 PM

Login with username, password and session length


Members
  • Total Members: 24070
  • Latest: sami
Stats
  • Total Posts: 647631
  • Total Topics: 49355
  • Online Today: 232
  • Online Ever: 585
  • (January 07, 2014, 02:31:47 PM)
Users Online

Welcome


Welcome to the POZ/AIDSmeds Community Forums, a round-the-clock discussion area for people with HIV/AIDS, their friends/family/caregivers, and others concerned about HIV/AIDS.  Click on the links below to browse our various forums; scroll down for a glance at the most recent posts; or join in the conversation yourself by registering on the left side of this page.

Privacy Warning:  Please realize that these forums are open to all, and are fully searchable via Google and other search engines. If you are HIV positive and disclose this in our forums, then it is almost the same thing as telling the whole world (or at least the World Wide Web). If this concerns you, then do not use a username or avatar that are self-identifying in any way. We do not allow the deletion of anything you post in these forums, so think before you post.

  • The information shared in these forums, by moderators and members, is designed to complement, not replace, the relationship between an individual and his/her own physician.

  • All members of these forums are, by default, not considered to be licensed medical providers. If otherwise, users must clearly define themselves as such.

  • Forums members must behave at all times with respect and honesty. Posting guidelines, including time-out and banning policies, have been established by the moderators of these forums. Click here for “Am I Infected?” posting guidelines. Click here for posting guidelines pertaining to all other POZ/AIDSmeds community forums.

  • We ask all forums members to provide references for health/medical/scientific information they provide, when it is not a personal experience being discussed. Please provide hyperlinks with full URLs or full citations of published works not available via the Internet. Additionally, all forums members must post information which are true and correct to their knowledge.

  • Product advertisement—including links; banners; editorial content; and clinical trial, study or survey participation—is strictly prohibited by forums members unless permission has been secured from POZ.

To change forums navigation language settings, click here (members only), Register now

Para cambiar sus preferencias de los foros en español, haz clic aquí (sólo miembros), Regístrate ahora

Finished Reading This? You can collapse this or any other box on this page by clicking the symbol in each box.

Author Topic: Bristol-Myers Squibb And ADAP Crisis Task Force  (Read 1397 times)

0 Members and 1 Guest are viewing this topic.

Offline J.R.E.

  • Member
  • Posts: 7,260
  • Joined Dec-2003 Living positive, since 1985.
Bristol-Myers Squibb And ADAP Crisis Task Force
« on: August 15, 2010, 03:45:10 AM »
http://www.medicalnewstoday.com/articles/197734.php


Bristol-Myers Squibb And ADAP Crisis Task Force Announce Enhanced, Multi-year Support For AIDS Drug Assistance Programs (ADAPs) In The United States
Main Category: HIV / AIDS
Also Included In: Preventive Medicine;  Pharma Industry / Biotech Industry;  Aid / Disasters
Article Date: 14 Aug 2010 - 2:00 PDT



Current Article Ratings:

Patient / Public:  4.5 (2 votes)
 


Bristol-Myers Squibb Company (NYSE: BMY) and the ADAP Crisis Task Force (ACTF) announced an enhanced agreement to support the efforts of AIDS Drug Assistance Programs (ADAPs) to provide antiretroviral medicines to people living with HIV and AIDS. Building on an agreement signed in March of 2010, today's announcement marks a multi-year enhancement to assist ADAPs in meeting the challenges of increasing patient case loads and strained government funding.

Bristol-Myers Squibb has worked with the ACTF since its inception in 2002 to help ensure access to HIV medications, such as REYATAZ® (atazanavir) and SUSTIVA® (efavirenz).

"AIDS Drug Assistance Programs are a critical safety net to ensure people living with HIV/AIDS who have no other resources can continue to receive the HIV treatments they need," said Dwayne Haught, spokesperson for the ADAP Crisis Task Force. "We commend Bristol-Myers Squibb for responding to the unprecedented need faced by state ADAPs to provide access to HIV medicines and enhance our March agreement by providing additional support. Our long working relationship with Bristol-Myers Squibb made this agreement possible."

"Ensuring access to treatment for HIV and AIDS requires the commitment and participation of government, industry and the community," said Lynda Dee of AIDS Action Baltimore and member of the Fair Pricing Coalition. "The Fair Pricing Coalition is pleased that Bristol-Myers Squibb continues to be a committed partner in meeting the needs of the HIV community."

"Bristol-Myers Squibb has a longstanding commitment to HIV and AIDS," said Raymond Sacchetti, senior vice president, U.S. Virology, Bristol-Myers Squibb. "We are proud to support the ADAP Crisis Task Force and applaud their ongoing efforts in working with state and federal officials to secure the funding needed to appropriately meet this challenging public health need."

In addition to enhancing the agreement with ACTF, Bristol-Myers Squibb offers people living with HIV/AIDS multiple ways to obtain medicine at reduced or no cost to the patient through the Bristol-Myers Squibb "Access Virology" program. Working directly with patients in need of assistance, the Access Virology program evaluates a person's eligibility for multiple prescription assistance programs that are offered, including:

Patient Assistance Program (PAP) provides:

-- Free Bristol-Myers Squibb HIV medicines to eligible patients based on medical and financial needs

-- "Fast tracking" of patients currently on an ADAP waiting list through accelerated advancement of their applications

-- A streamlined application process and eligibility criteria to help patients applying for medicine access

REYATAZ® (atazanavir) and SUSTIVA® (efavirenz) Co-pay Benefit Program:

-- Designed for eligible patients with commercial insurance coverage

-- Bristol-Myers Squibb will pay the first $200/month ($2,400/year) of an eligible patient's out-of-pocket co-pay costs for up to one year

Bristol-Myers Squibb also participates in the Partnership for Prescription Assistance and Together Rx Access®. The Partnership for Prescription Assistance is an innovative program that helps connect patients with no prescription drug coverage to both public and private patient assistance programs. Together Rx Access® offers eligible patients discounts for prescription medicines.

Additionally, Bristol-Myers Squibb & Gilead Sciences, LLC, have recently enhanced the ATRIPLA® (efavirenz 600 mg/emtricitabine 200 mg/tenofovir disoproxil fumarate [DF] 300 mg) Co-Pay Assistance Program to cover up to the first $200 per month (or $2,400 per year) of related out-of-pocket expenses for commercially insured patients that have been prescribed ATRIPLA.

Source: Bristol-Myers Squibb


Current Meds ; Viramune, Epzicom, 40mg of simvastatin, 25 mg of Hydrochlorothiazide.
Metoprolol tartrate 25mg



http://forums.poz.com/index.php?topic=40802.0

http://forums.poz.com/index.php?topic=45159.0

http://forums.poz.com/index.php?topic=39722.msg495621;topicseen#msg495621

http://forums.poz.com/index.php?topic=46806.0

http://forums.poz.com/index.php?topic=39414.msg491701#msg491701


Diagnosed positive in 1985,.. In October of 2003, My t-cell count was 16, Viral load was over 500,000, Percentage at that time was 5%. I started on  HAART on October 24th, 2003.

 As of 8/25/14,  t-cells are at 402, Viral load <40

 Current % is at 11%

  
 62 years young.

Offline leatherman

  • Member
  • Posts: 6,307
  • Google and HIV meds are Your Friends
Re: Bristol-Myers Squibb And ADAP Crisis Task Force
« Reply #1 on: August 15, 2010, 08:58:56 AM »
thanks for that news! ;)
it's good to hear that there'll  be more help with more of the meds. In these days with the ADAP problems across the country, every little bit is sure to help. ;D
leatherman (aka mIkIE)


chart from 1992-2013; updated 2/09/13  Reyataz/Norvir/Truvada

Offline WillyWump

  • Member
  • Posts: 7,245
Re: Bristol-Myers Squibb And ADAP Crisis Task Force
« Reply #2 on: August 15, 2010, 04:17:30 PM »
Yes this is good news,as leather says every little bit helps.

-Will
POZ since '08

Last Labs-
11-6-14 CD4- 871, UD
6/3/14 CD4- 736, UD 34%
6/25/13 CD4- 1036, UD,
2/4/13, CD4 - 489, UD, 28%

Current Meds: Prezista/Epzicom/ Norvir
.

Offline BlueMoon

  • Member
  • Posts: 665
  • Calling from the Fun House
Re: Bristol-Myers Squibb And ADAP Crisis Task Force
« Reply #3 on: August 15, 2010, 05:14:16 PM »
Yes this is good news,as leather says every little bit helps.

-Will

It can be more than a little bit.  When I was dropped from ADAP last month I was facing crushing copays; $711 a month, or about $630 if I bought 90-day supplies by mail.  The assistance from the four manufacturers of my regimen brought it down to $62 a month.  I can get it down to $30 if I use mail-order, but Medco by Mail doesn't accept the cards, so I would have to pay up front and then get reimbursed by the manufacturers (which they do).  Right now it's worth the extra $32 a month to not have to deal with the extra paperwork, and Medco by Mail in general.   ::)

It's good to see the manufacturers step up, even if it's only to protect their market shares.  I still look forward to the day when patients don't have to beg for the money to stay alive.





...................VL.....CD4.....%
-----------------------------------------
08/10-- ......<40.....290.....42
05/10-- ......<48.....290.....46
02/10-- ......<48.....481.....44
10/09-- ......<48.....277.....46
07/09-- ......<48.....300.....38
05/09-- ........51.....449.....39
03/09-- Added Isentress
02/09-- ........65.....299.....34
11/08-- ........62.....242.....40
08/08-- ........66.....212.....29
05/08-- ......202.....217.....27
03/08-- ....5210.....187.....21
02/08-- Began Truvada/Reyataz/Norvir
12/07-- 273,000.....157.....22
11/07-- 229,000.....209.....22
10/07-- Diagnosis

It's a complex world.

Offline leatherman

  • Member
  • Posts: 6,307
  • Google and HIV meds are Your Friends
Re: Bristol-Myers Squibb And ADAP Crisis Task Force
« Reply #4 on: August 16, 2010, 12:03:04 AM »
I still look forward to the day when patients don't have to beg for the money to stay alive.
Amen brother! ;)
leatherman (aka mIkIE)


chart from 1992-2013; updated 2/09/13  Reyataz/Norvir/Truvada

 


Terms of Membership for these forums
 

© 2014 Smart + Strong. All Rights Reserved.   terms of use and your privacy
Smart + Strong® is a registered trademark of CDM Publishing, LLC.